James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Shutterstock, Windstream Holdings and Westlake Chemical Are 3 of Today’s Worst Stocks

Windstream Holdings, Shutterstock and Westlake Chemical sucker-punched shareholders on Friday. Here's what went so wrong for each.

Teva Raises Warning for All Makers of Generic Drugs

Generic drugs are no longer the alternative. They're mainstream, and here to stay. Investors need to recognize what this really means for healthcare stocks.

Why GoPro, Mobile TeleSystems and Teck Resources Are 3 of Today’s Worst Stocks

Thursday was anything but a good day for GoPro, Mobile TeleSystems and Teck Resources. Here's what investors need to know.

Why Sprint, Atlas Pipeline Partners and Wynn Resorts Are 3 of Today’s Worst Stocks

Sprint Corporation, Atlas Pipeline Partners, and Wynn Resorts were the worst of the worst on Wednesday. Here's the deal.

Lands’ End Earnings Are Encouraging Despite Selloff

Lands' End earnings figures for its third quarter were great, or alarming, depending on your perspective.